He aha ʻo Satralizumab: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau kūikawā ʻo Satralizumab i hoʻolālā ʻia e pale i nā relapses i ka maʻi spectrum neuromyelitis optica (NMOSD), he maʻi autoimmune kakaʻikahi e hoʻouka ana i nā aʻalolo optic a me ke kuamoʻo. Hana kēia lāʻau lapaʻau i ka pale ʻana i nā hōʻailona ʻōnaehana immune e hoʻoulu ai i ka mumū a me ka pōʻino i kāu ʻōnaehana nerve.

Inā ua ʻike ʻia ʻoe a i ʻole kekahi āu e mālama nei me NMOSD, nui paha kāu mau nīnau e pili ana i kēia koho lapaʻau. ʻO ka hoʻomaopopo ʻana i ka hana ʻana o satralizumab a me ka mea e manaʻo ai hiki ke kōkua iā ʻoe e ʻoi aku ka hilinaʻi i kāu mau hoʻoholo mālama ola.

He aha ʻo Satralizumab?

ʻO Satralizumab he antibody i hana ʻia i loko o ka hale hana e kuhikuhi pono ana i ka interleukin-6 (IL-6), he protein e pāʻani nui i ka mumū. E noʻonoʻo iā IL-6 ma ke ʻano he ʻelele e haʻi ana i kāu ʻōnaehana immune e hana i ka mumū, i ka NMOSD hiki ke hōʻino i kāu mau aʻalolo optic a me ke kuamoʻo.

No ka papa o nā lāʻau i kapa ʻia he monoclonal antibodies kēia lāʻau lapaʻau. Hoʻolālā ʻia kēia mau mea e pololei loa i kā lākou hana, e kuhikuhi ana i nā ʻāpana kikoʻī o kāu ʻōnaehana immune ma mua o ka hoʻopau ʻana i kāu pane immune holoʻokoʻa.

Hele mai ka lāʻau lapaʻau ma ke ʻano he syringe i hoʻopiha mua ʻia āu e hoʻokomo ai ma lalo o kou ʻili (subcutaneously). E aʻo kāu hui mālama ola iā ʻoe pehea e hāʻawi ai iā ʻoe iho i kēia mau injections me ka palekana ma ka home, e maʻalahi ai ka mālama ʻana i kāu hana i kēlā me kēia lā.

No ke aha i hoʻohana ʻia ai ʻo Satralizumab?

Ua ʻae ʻia ʻo Satralizumab e pale i nā relapses i nā pākeke me ka maʻi spectrum neuromyelitis optica (NMOSD). ʻO ka relapse ʻo ia hoʻi, e hoʻi mai ana a i ʻole e ʻinoʻino ana kāu mau hōʻailona, ​​e komo pū ana me nā pilikia o ka ʻike, ka nāwaliwali, ka ʻeha, a i ʻole ka pilikia me ka hoʻonohonoho.

Hiki i kāu kauka ke kuhikuhi iā satralizumab inā he AQP4-IgG maikaʻi kāu NMOSD, ʻo ia hoʻi, hōʻike nā hoʻokolohua koko he mau antibodies kūikawā kāu e hoʻouka i kahi protein i kapa ʻia ʻo aquaporin-4. Aia kēia protein i loko o kou lolo a me ke kuamoʻo, a i ka wā e hoʻouka ai kou ʻōnaehana pale, e hana ia i nā hōʻailona o NMOSD.

Hiki ke hoʻohana ʻia ka lāʻau lapaʻau wale nō a i ʻole me nā lāʻau lapaʻau ʻē aʻe e like me nā corticosteroids a i ʻole nā lāʻau immunosuppressive. E hoʻoholo kāu mea mālama ola i ke ala hui maikaʻi loa e pili ana i kou kūlana kikoʻī a me ka mōʻaukala olakino.

Pehea e hana ai ʻo Satralizumab?

Hana ʻo Satralizumab ma ka pale ʻana i ka interleukin-6 (IL-6), kahi protein e hoʻoulu ai i ka mumū i loko o kou ʻōnaehana nerve. Ke hana ʻo IL-6, hoʻouna ia i nā hōʻailona e hoʻoulu ai i kou ʻōnaehana pale e hoʻouka i nā ʻiʻo olakino i loko o kou mau aʻalolo optic a me ke kuamoʻo.

Ma ka hoʻopaʻa ʻana iā IL-6 a pale iā ia mai ka hana ʻana, kōkua ʻo satralizumab i ka hōʻemi ʻana i ka mumū e hana ai i nā relapses NMOSD. Manaʻo ʻia kēia he ala i manaʻo ʻia no ka mea e kālele ana i hoʻokahi ʻāpana kikoʻī o ka pane ʻana o ka immune ma mua o ka hoʻopaʻa ʻana i kāu ʻōnaehana pale holoʻokoʻa.

Manaʻo ʻia ka lāʻau lapaʻau he ikaika iki i kāna mau hopena e hoʻopaʻa ana i ka immune. ʻOiai ʻaʻole ia e pani loa i kāu ʻōnaehana pale e like me kekahi mau lāʻau lapaʻau ʻē aʻe, hana ia i nā loli i manaʻo ʻia e hiki ke hoʻopilikia i ka hiki o kou kino ke hakakā i kekahi mau maʻi.

Pehea wau e lawe ai iā Satralizumab?

Hāʻawi ʻia ʻo Satralizumab ma ke ʻano he injection subcutaneous, ʻo ia hoʻi, hoʻokomo ʻoe iā ia i loko o ka ʻiʻo momona ma lalo pono o kou ʻili. Hāʻawi ʻia ka injection i loko o kou ʻūhā, ka lima luna, a i ʻole ka ʻōpū, e hoʻololi ana ma waena o nā wahi like ʻole e pale ai i ka huhū.

E loaʻa iā ʻoe kāu mau mahele ʻekolu mua i nā pule 0, 2, a me 4, a laila e hahai ʻia e nā mahele i kēlā me kēia 4 pule ma hope. E aʻo kāu hui mālama ola iā ʻoe i ke ʻano o ka injection kūpono a hāʻawi i nā ʻōlelo kikoʻī no ka mālama ʻana a me ka lawelawe ʻana i ka lāʻau lapaʻau.

Ma mua o kēlā me kēia injection, e lawe i ka lāʻau lapaʻau mai loko mai o ka pahu hau a e hoʻokuʻu iā ia e hiki i ka mahana o ka lumi no kahi o 30 mau minuke. Kōkua kēia i ka hōʻemi ʻana i ka ʻoluʻolu ʻole i ka wā o ka injection. Hiki iā ʻoe ke lawe i ka satralizumab me ka ʻole o ka meaʻai, no ka mea, ʻaʻole ia e launa pū me nā meaʻai.

E holoi mau i kou mau lima me ka maikaʻi ma mua o ka lawelawe ʻana i ka lāʻau lapaʻau a me nā lako injection. E koho i kahi wahi maʻemaʻe a ʻoluʻolu no kāu injection, a mai hoʻohana hou i nā nila a i ʻole nā syringes.

Pehea ka lōʻihi e lawe ai au i ka Satralizumab?

Ua manaʻo ʻia ʻo Satralizumab he lapaʻau lōʻihi no NMOSD. Hoʻomau ka hapa nui o nā kānaka i ka lawe ʻana iā ia no ka manawa pau ʻole e mālama i ka pale ʻana i nā relapses, no ka mea, ʻo ka hoʻōki ʻana i ka lāʻau lapaʻau e hiki ai i kou maʻi ke hana hou.

E nānā mau kāu kauka i kāu pane ʻana i ka lapaʻau a e loiloi inā e hoʻomau ana ka satralizumab i ka maikaʻi iā ʻoe. ʻO kēia mau nānā ʻana e pili ana i nā hoʻokolohua koko, nā hoʻokolohua neurological, a me nā kūkākūkā e pili ana i nā hōʻailona a i ʻole nā hopena ʻaoʻao āu e ʻike nei.

ʻO ka hoʻoholo e hoʻomau a hoʻōki paha i ka satralizumab e hana mau ʻia ma ka hui pū ʻana me kāu hui mālama ola. E noʻonoʻo lākou i nā mea e like me ka maikaʻi o ka hana ʻana o ka lāʻau lapaʻau, nā hopena ʻaoʻao āu e ʻike nei, a me nā loli i kou kūlana olakino holoʻokoʻa.

He aha nā hopena ʻaoʻao o Satralizumab?

E like me nā lāʻau lapaʻau a pau, hiki i ka satralizumab ke hana i nā hopena ʻaoʻao, ʻoiai ʻaʻole i ʻike nā kānaka a pau iā lākou. ʻO ka hapa nui o nā hopena ʻaoʻao he maʻalahi a me ka maʻalahi a hiki ke mālama ʻia me ka nānā pono a me ka mālama.

ʻO ka hoʻomaopopo ʻana i ka mea e nānā ai hiki ke kōkua iā ʻoe e mākaukau a ʻike i ka manawa e hoʻokaʻaʻike aku ai i kāu hui mālama ola. Eia nā hopena ʻaoʻao maʻamau e hiki ai iā ʻoe ke ʻike:

• Nā hopena ma ka pūnaewele injection e like me ka ʻulaʻula, ka pehu, a i ʻole ka ʻeha maʻalahi
• Nā maʻi hanu luna e like me ke anu a i ʻole nā maʻi sinus
• Nā poʻo e hiki ke hana i kekahi manawa
• ʻO ka ʻili a i ʻole ka ʻili
• ʻO ka luhi a i ʻole ka manaʻo e luhi ma mua o ka maʻamau

ʻO kēia mau hopena ʻaoʻao maʻamau he mea manawa wale nō ia a pinepine e hoʻomaikaʻi ana i ka wā e hoʻoponopono ai kou kino i ka lāʻau. ʻO ka hapa nui o nā kānaka e ʻike he mea hiki ke mālama ʻia a ʻaʻole pono e hooki i ka lapaʻau ma muli o lākou.

ʻO nā hopena ʻaoʻao koʻikoʻi ʻaʻole maʻamau akā pono e loaʻa ka lāʻau lapaʻau koke. Aia kēia mau mea i nā hōʻailona o ka maʻi koʻikoʻi, nā hopena maʻi maʻi koʻikoʻi, a i ʻole ke kahe ʻana a i ʻole ka ʻeha ʻana.

No ka mea e pili ana ka satralizumab i kāu ʻōnaehana pale, hiki iā ʻoe ke loaʻa i kahi pilikia liʻiliʻi no nā maʻi. E nānā pono kāu hui mālama ola iā ʻoe a hāʻawi i ke alakaʻi ʻana i ka ʻike ʻana i nā hōʻailona o ka maʻi e pono ai ka lapaʻau wikiwiki.

ʻO wai ka mea ʻaʻole pono e lawe i ka Satralizumab?

ʻAʻole kūpono ka Satralizumab no nā mea a pau me NMOSD. E loiloi pono kāu kauka inā palekana a kūpono kēia lāʻau lapaʻau no kāu kūlana.

ʻAʻole pono ʻoe e lawe i ka satralizumab inā loaʻa iā ʻoe kahi maʻi koʻikoʻi, no ka mea, hiki i ka lāʻau lapaʻau ke paʻakikī i kou kino ke pale aku i nā maʻi. Aia kēia i nā maʻi bacteria, viral, fungal, a i ʻole nā maʻi kūpono ʻē aʻe e pono ai ka lapaʻau mua.

Pono paha ka poʻe me kekahi mau maʻi ate i ka nānā ʻana a i ʻole ʻaʻole paha he moho no ka satralizumab. E nānā kāu kauka i kāu hana ate me nā hoʻokolohua koko ma mua o ka hoʻomaka ʻana i ka lapaʻau a nānā mau.

Inā hāpai ʻoe, e hoʻolālā ana e hāpai, a i ʻole e hānai ana i ka waiū, e kūkākūkā pono i kēia me kāu hui mālama ola. ʻOiai he palena nā ʻikepili e pili ana i ka hoʻohana ʻana i ka satralizumab i ka wā hāpai, e kaupaona kāu kauka i nā pōmaikaʻi a me nā pilikia no kāu kūlana.

E haʻi i kāu mea mālama ola e pili ana i nā lāʻau lapaʻau ʻē aʻe āu e lawe nei, me nā lāʻau lapaʻau i kauoha ʻia, nā lāʻau lapaʻau ma luna o ka pāʻani, a me nā mea hoʻohui. Pono paha kekahi mau hui i nā hoʻoponopono ʻana i ka dosis a i ʻole ka nānā ʻana.

Nā inoa inoa inoa Satralizumab

Hoʻolaha ʻia ka Satralizumab ma lalo o ka inoa inoa Enspryng. ʻO kēia ka inoa āu e ʻike ai ma kāu lepili kauoha a me ka ʻeke lāʻau.

ʻO ka inoa ʻenehana piha ʻo satralizumab-mwge, e hōʻike ana i ka hana kikoʻī a me ke kaʻina hana. Eia naʻe, ʻo ka hapa nui o nā mea mālama ola a me nā hale kūʻai lāʻau lapaʻau e kuhikuhi iā ia ma ke ʻano he Enspryng i ke kamaʻilio ʻana i kēlā me kēia lā.

Ke kūkākūkā ʻana i kāu lapaʻau me nā mea mālama ola like ʻole a i ʻole nā hale kūʻai lāʻau lapaʻau, hiki iā ʻoe ke hoʻohana i kekahi inoa. Hiki ke kōkua ka loaʻa ʻana o nā inoa ʻelua i ke kākau ʻana i ka wā e hoʻopili ai i kāu mālama a i ʻole ka uhi ʻinikua.

Nā Koho ʻē aʻe o Satralizumab

Nui nā lāʻau lapaʻau ʻē aʻe e hiki ke mālama i ka NMOSD, a hiki i kāu kauka ke noʻonoʻo i nā koho ʻē aʻe e pili ana i kāu kūlana kikoʻī, ka pane ʻana i ka lapaʻau, a i ʻole nā makemake pilikino. Aia ke koho i nā mea e like me ke kūlana o kāu antibody, nā lapaʻau mua, a me ke olakino holoʻokoʻa.

ʻO nā koho ʻē aʻe i ʻae ʻia e ka FDA no ka NMOSD me ka eculizumab (Soliris) a me ka inebilizumab (Uplizna). Hana ʻokoʻa kēlā me kēia i kāu ʻōnaehana pale a loaʻa nā pōmaikaʻi a me nā manaʻo ponoʻī.

Hoʻohana pū ʻia nā lāʻau lapaʻau immunosuppressive kuʻuna e like me azathioprine, mycophenolate mofetil, a i ʻole rituximab e pale ai i nā relapses NMOSD. Ua hoʻohana ʻia kēia mau mea no ka lōʻihi a ʻoi aku ka maʻalahi, akā pono lākou i ka nānā ʻana like ʻole a loaʻa paha nā ʻaoʻao ʻokoʻa.

E kōkua kāu hui mālama ola iā ʻoe e hoʻomaopopo i nā pono a me nā pōʻino o kēlā me kēia koho. ʻO ke koho maikaʻi loa no ʻoe e pili ana i kāu kūlana olakino pilikino, nā mea ola, a me nā pahuhopu lapaʻau.

Ua ʻoi aku ka maikaʻi o Satralizumab ma mua o nā lapaʻau NMOSD ʻē aʻe?

ʻAʻole maʻalahi ka hoʻohālikelike ʻana i nā lapaʻau NMOSD no ka mea hana ʻokoʻa kēlā me kēia lāʻau lapaʻau a ʻoi aku paha ka maikaʻi no nā kānaka like ʻole. Hāʻawi ʻo Satralizumab i kekahi mau mea maikaʻi kūʻokoʻa, akā inā he

Ua hōʻike nā haʻawina lapaʻau i ka satralizumab he mea pono i ka hoʻēmi ʻana i nā helu relapse i nā kānaka me AQP4-IgG maikaʻi NMOSD. Akā naʻe, ua kaupalena ʻia nā hoʻohālikelike poʻo-i-poʻo pololei me nā lāʻau lapaʻau hou.

E noʻonoʻo kāu kauka i nā mea e like me ke kūlana o kāu antibody, nā pane lapaʻau mua, nā makemake o ke ola, ka uhi ʻinikua, a me ke olakino holoʻokoʻa i ka wā e ʻōlelo ai i ka koho maikaʻi loa no ʻoe. ʻAʻole paha ka mea e hana maikaʻi loa no kekahi kanaka ke koho kūpono no kekahi.

Nā Nīnau i Nīnau Pinepine ʻia e pili ana iā Satralizumab

He Palekana anei ʻo Satralizumab no nā Kānaka me nā Kūlana Autoimmune ʻē aʻe?

Inā he mau kūlana autoimmune ʻē aʻe kāu ma waho o NMOSD, he koho nō paha ʻo satralizumab, akā pono ia i ka loiloi akahele. E loiloi kāu kauka i ke ʻano o ka launa ʻana o satralizumab me kāu mau kūlana a me nā lāʻau lapaʻau ʻē aʻe.

Loaʻa i kekahi poʻe me NMOSD nā kūlana e like me ka lupus, Sjögren's syndrome, a i ʻole nā maʻi autoimmune ʻē aʻe. Hiki i nā hopena immune-suppressing o satralizumab ke hoʻopilikia i kēia mau kūlana, maikaʻi a maikaʻi ʻole paha.

E hana pū kāu hui mālama ola me nā loea e mālama ana i kāu mau kūlana ʻē aʻe e hōʻoia i ka hana pū ʻana o kāu mau lāʻau lapaʻau a pau me ka palekana. Hiki i kēia ke hoʻololi i nā lāʻau lapaʻau ʻē aʻe a i ʻole ka hoʻonui ʻana i ka nānā ʻana i ka wā o ka mālama ʻana.

He aha kaʻu e hana ai inā hoʻohana hewa au i ka nui o Satralizumab?

Inā ʻoe e hoʻokomo hewa i ka satralizumab ma mua o ka mea i kauoha ʻia, e hoʻokaʻaʻike koke i kāu mea mālama ola no ke alakaʻi. ʻOiai ʻaʻole paha he overdose me satralizumab ma muli o kāna ʻano syringe i hoʻopiha mua ʻia, he mea nui e hōʻike i nā hewa dosing.

Mai ho'āʻo e

E mālama i ka ʻike pili o kāu mea mālama ola ma kahi e maʻalahi ai ke kiʻi, a mai kānalua e kelepona inā he hopohopo kāu e pili ana i kāu ʻenehana injection a i ʻole ka hoʻohana ʻana i ka lāʻau.

He aha kaʻu e hana ai inā ua hala wau i kahi lāʻau o Satralizumab?

Inā ua hala ʻoe i kahi lāʻau i hoʻonohonoho ʻia o satralizumab, e kelepona i kāu mea mālama ola i ka hiki wawe e loaʻa ke alakaʻi i ka manawa e lawe ai i kāu injection e hiki mai ana. E hilinaʻi ka manawa i ka lōʻihi o ka manawa mai kāu lāʻau i hala.

Ma keʻano maʻamau, inā hoʻomanaʻo ʻoe i loko o kekahi mau lā o kāu lāʻau i hoʻonohonoho ʻia, e ʻōlelo ʻia paha ʻoe e lawe i ka hiki wawe a laila e hoʻomau me kāu papa manawa maʻamau. Inā ua hala ka manawa hou, hiki i kāu kauka ke hoʻoponopono i kāu papa manawa hoʻohana.

Mai pāpālua i nā lāʻau a i ʻole e hoʻāʻo e hopu ma ka lawe ʻana i nā lāʻau hou. ʻO ka hoʻomau ʻana i ka manawa e kōkua i ka mālama ʻana i nā pae paʻa o ka lāʻau i loko o kāu ʻōnaehana no ka pono maikaʻi loa.

I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Satralizumab?

Pono e hana mau ʻia ka hoʻoholo e hooki i ka satralizumab ma ke kūkākūkā ʻana me kāu hui mālama ola. Pono ka hapa nui o nā kānaka me NMOSD i ka lāʻau lōʻihi e pale i nā relapses, no laila pono ka noʻonoʻo pono ʻana i ka hooki ʻana i ka lāʻau.

Hiki i kāu kauka ke noʻonoʻo e hooki i ka satralizumab inā loaʻa iā ʻoe nā hopena ʻaoʻao koʻikoʻi e ʻoi aku ana i nā pōmaikaʻi, inā ʻaʻole pono ka lāʻau, a i ʻole inā loli nui kou kūlana.

Inā ʻoe e noʻonoʻo ana e hooki i ka lāʻau no nā kumu pilikino, e kūkākūkā ākea me kāu hui mālama ola. Hiki iā lākou ke kōkua iā ʻoe e hoʻomaopopo i nā pilikia a me nā pōmaikaʻi a e ʻimi i nā koho lapaʻau ʻē aʻe inā pono.

Hiki iaʻu ke hele i ka wā e lawe ana iā Satralizumab?

ʻAe, hiki iā ʻoe ke hele i ka wā e lawe ana iā satralizumab, akā pono ia i kekahi hoʻolālā e hōʻoia e hiki iā ʻoe ke mālama i kāu papa manawa lapaʻau. Pono e mālama ʻia ka lāʻau i loko o ka pahu hau, no laila pono ʻoe e hoʻolālā no ka mālama pono ʻana i ka wā e hele ai.

No ka huakaʻi pōkole, hiki iā ʻoe ke hoʻohana i ka pahu hau me nā pūʻolo hau e mālama i ka lāʻau i ka mahana kūpono. No nā huakaʻi lōʻihi, pono paha ʻoe e hoʻonohonoho i ka lawe ʻana i ka lāʻau i kou wahi e hele ai a i ʻole e hoʻopili me nā mea mālama ola ma kahi āu e hele nei.

E lawe mau i kahi leka mai kāu kauka e wehewehe ana i kou maʻi a me ka pono no ka lāʻau, ʻoiai ke hele nei i nā ʻāina ʻē. Hiki i kēia ke kōkua i nā hana maʻamau a me nā wahi palekana.